Sarepta Therapeutics, Inc. (SRPT)
16.69
+0.04
(+0.24%)
USD |
NASDAQ |
Mar 20, 16:00
16.73
+0.04
(+0.24%)
After-Hours: 20:00
Sarepta Therapeutics Accounts Payable (Quarterly) : 280.84M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Keros Therapeutics, Inc. | 1.967M |
| Merck & Co., Inc. | 4.404B |
| PTC Therapeutics, Inc. | 45.49M |
| REGENXBIO, Inc. | 21.36M |
| Gilead Sciences, Inc. | 715.00M |